Cargando…

Validity of a novel screen for cognitive impairment and neuropsychiatric symptoms in cardiac rehabilitation

BACKGROUND: Currently, there is no composite screening tool that can efficiently and effectively assess prevalent yet under-recognized cognitive and neuropsychiatric comorbidities in patients with cardiovascular disease. We aimed to determine the validity and feasibility of a novel screen assessing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammad, Dana, Herrmann, Nathan, Saleem, Mahwesh, Swartz, Richard H., Oh, Paul I., Bradley, Janelle, Chan, Parco, Ellis, Courtney, Lanctôt, Krista L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558737/ https://www.ncbi.nlm.nih.gov/pubmed/31185923 http://dx.doi.org/10.1186/s12877-019-1177-0

Ejemplares similares

Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation
por: Santiago, Calvin, et al.
Publicado: (2017)

Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study
por: Chan, Parco, et al.
Publicado: (2018)

Association Between Endothelial Function and Cognitive Performance in Patients With Coronary Artery Disease During Cardiac Rehabilitation
por: Saleem, Mahwesh, et al.
Publicado: (2019)

Higher Cortisol Predicts Less Improvement in Verbal Memory Performance after Cardiac Rehabilitation in Patients with Coronary Artery Disease
por: Saleem, Mahwesh, et al.
Publicado: (2013)

Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment
por: Suridjan, Ivonne, et al.
Publicado: (2017)

Association Between Sphingolipids and Cardiopulmonary Fitness in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation
por: Saleem, Mahwesh, et al.
Publicado: (2020)

Is Cardiac Rehabilitation Exercise Feasible for People with Mild Cognitive Impairment?
por: Intzandt, Brittany, et al.
Publicado: (2015)

Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review
por: Lai, Ka Sing Paris, et al.
Publicado: (2015)

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
por: Benhabib, Hadas, et al.
Publicado: (2013)

Glutathione Peroxidase Activity Is Altered in Vascular Cognitive Impairment-No Dementia and Is a Potential Marker for Verbal Memory Performance
por: Ahmed, Mehnaz, et al.
Publicado: (2021)

Plasma sphingolipids and depressive symptoms in coronary artery disease
por: Dinoff, Adam, et al.
Publicado: (2017)

Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
por: Rej, Soham, et al.
Publicado: (2016)

Endostatin as a Mediator Between Endothelial Function and Cognitive Performance in Those at Risk for Vascular Cognitive Impairment
por: Isaacs-Trepanier, Cameron, et al.
Publicado: (2020)

Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease
por: Chan, Parco, et al.
Publicado: (2018)

Cardiopulmonary Fitness Correlates with Regional Cerebral Grey Matter Perfusion and Density in Men with Coronary Artery Disease
por: MacIntosh, Bradley J., et al.
Publicado: (2014)

Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress
por: Swardfager, W., et al.
Publicado: (2014)

Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017
por: Kim, Doyoung, et al.
Publicado: (2019)

Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33–35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study
por: Papenburg, Jesse, et al.
Publicado: (2020)

Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
por: Clark, Emily D., et al.
Publicado: (2023)

Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study
por: Saleem, Mahwesh, et al.
Publicado: (2013)

Neuropsychiatric symptoms in Mild Cognitive Impairment
por: Algin, Demet İlhan, et al.
Publicado: (2010)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Neuropsychiatric symptoms in Vascular Cognitive Impairment: a systematic review
por: Tiel, Chan, et al.
Publicado: (2015)

Rehabilitation of Neuropsychiatric Symptoms in Patients With Long COVID: Position Statement
por: Sacks-Zimmerman, Amanda, et al.
Publicado: (2023)

Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
por: Dowlati, Yekta, et al.
Publicado: (2010)

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
por: Lanctôt, Krista L., et al.
Publicado: (2017)

Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention
por: Chen, Jinghan Jenny, et al.
Publicado: (2015)

Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia
por: Wilson, Robert S., et al.
Publicado: (2021)

Comparing the distribution of neuropsychiatric symptoms among individuals with depression and mild cognitive impairment
por: Keng, A., et al.
Publicado: (2023)

Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study
por: Mazereeuw, Graham, et al.
Publicado: (2015)

Kynurenine and depressive symptoms in a poststroke population
por: Bensimon, Kira, et al.
Publicado: (2014)

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Herrmann, Nathan, et al.
Publicado: (2013)

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial
por: Mazereeuw, Graham, et al.
Publicado: (2016)

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
por: Leroi, Iracema, et al.
Publicado: (2012)

The “DOC” screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics
por: Swartz, Richard H., et al.
Publicado: (2017)

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
por: Liu, Celina S., et al.
Publicado: (2020)

Neuropsychiatric symptoms and executive function impairments in Alzheimer’s disease and vascular dementia: The role of subcortical circuits
por: Tiel, Chan, et al.
Publicado: (2019)

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
por: Gold, Allison B, et al.
Publicado: (2011)

Neuropsychiatric symptoms in mild cognitive impairment: An analysis and its impact on caregiving
por: Trivedi, Surbhi C., et al.
Publicado: (2013)

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression
por: Zhang, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ov7rs08dluqmo4rkmeklstkhjb